PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
Authors:
- Marie-Christine HeinrichMHMarie-Christine Heinrich
- Cosima GöbelCGCosima Göbel
- Martina KluthMKMartina Kluth
- Christian BernreutherCBChristian Bernreuther
- Charlotte SauerCSCharlotte Sauer
- Cornelia SchroederCSCornelia Schroeder
- Christina Möller-KoopCMChristina Möller-Koop
- Claudia Hube-MaggCHClaudia Hube-Magg
- Patrick LebokPLPatrick Lebok
- Eike BurandtEBEike Burandt
- Guido SauterGSGuido Sauter
- Ronald SimonRSRonald Simon
Open Access
- 31 May 2018
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 612
Abstract
Prostate Stem Cell Antigen (PSCA) is frequently expressed in prostate cancer but its exact function is unclear. To clarify contradictory findings on the prognostic role of PSCA expression, a tissue microarray containing 13,665 prostate cancers was analyzed by immunohistochemistry. PSCA staining was absent in normal epithelial and stromal cells of the prostate. Membranous and cytoplasmic PSCA staining was seen in 53.7% of 9642 interpretable tumors. Staining was weak in 22.4%, moderate in 24.5% and strong in 6.8% of tumors. PSCA expression was associated with favorable pathological and clinical tumor features: Early pathological tumor stage (p < 0.0001), low Gleason grade (p < 0.0001), absence of lymph node metastasis (p < 0.0001), low pre-operative PSA level (p = 0.0118), negative surgical margin (p < 0.0001) and reduced PSA recurrence (p < 0.0001). PSCA expression was an independent predictor of prognosis in multivariate analysis (hazard ratio 0.84, p < 0.0001). The absence of statistical relationship to TMPRSS2:ERG fusion status, chromosomal deletion or high tumor cell proliferation argues against a major role of PSCA for regulation of cell cycle or genomic integrity. PSCA expression is linked to favorable prognosis. PSCA measurement is a candidate for inclusion in multi-parametric prognostic prostate cancer tests.Keywords
This publication has 47 references indexed in Scilit:
- Detection of Prostate Stem Cell Antigen Expression in Human Prostate Cancer Using Quantum-Dot-Based TechnologySensors, 2012
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingBMC Cancer, 2011
- Identification of markers of prostate cancer progression using candidate gene expressionBritish Journal of Cancer, 2011
- Up-regulated biglycan expression correlates with the malignancy in human colorectal cancersClinical and Experimental Medicine, 2011
- Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule?Clinical Cancer Research, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate CancerClinical Cancer Research, 2010
- Prostate stem cell antigen: A prospective therapeutic and diagnostic targetCancer Letters, 2009
- Clinical significance of p53 alterations in surgically treated prostate cancersLaboratory Investigation, 2008
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005